Orion OYJ (OTCMKTS:ORINY) Reaches New 52-Week High – Here’s Why

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $45.25 and last traded at $45.25, with a volume of 598 shares. The stock had previously closed at $43.0160.

Orion OYJ Stock Performance

The company has a 50-day simple moving average of $41.07 and a two-hundred day simple moving average of $39.65. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The firm has a market capitalization of $12.77 billion, a P/E ratio of 18.62 and a beta of 0.07.

Orion OYJ (OTCMKTS:ORINY) last announced its earnings results on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The firm had revenue of $606.38 million during the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.